Tirofiban After Successful MT Recanalization in AIS
Studying Androgen insensitivity syndrome
Last synced from ClinicalTrials.gov
Key facts
- Sponsor
- Xiang Luo
- Principal Investigator
- Xiang LuoTongji Hospital
- Intervention
- Tirofiban(drug)
- Enrollment
- 1380 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2024 – 2025
Study locations (1)
- Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
Collaborators
Fujian Medical University Union Hospital · Jingzhou Hospital Affiliated to Yangtze University · Xiangyang No 1 People's Hospital Affiliated to Hubei University of Medicine · Puren Hospital Affiliated to Wuhan University of Science and Technology · Zhongnan Hospital · First Affiliated Hospital of Fujian Medical University · Wuhan Central Hospital · Xianning Central Hospital · Shanxi Provincial People's Hospital · The Third People's Hospital of Hubei Province · Jingmen Central Hospital · Hubei University of Medicine · Wuhan No.1 Hospital · Nanyang Central Hospital · Yichang Central People's Hospital of China Three Gorges University · The Central Hospital of Huanggang · Zoucheng City People's Hospital · Qujing Central Hospital of Yunnan Province · Taihe Hospital, Affiliated Hospital of Hubei Province of Medicine · Second Affiliated Hospital of Soochow University · The First Affiliated Hospital of Nanchang University · Central Hospital of Xiaogan · The Central Hospital of Enshi Tujia And Miao Autonomous Prefecture · Huangshi Central Hospital · Zigong No.1 Peoples Hospital · Xiangyang Hospital of Traditional Chinese Medicine · The First People's Hospital of Jingzhou City · First People's Hospital of Xianyang · Jiujiang No.1 People's Hospital · Zhongxiang Hospital of Traditional Chinese Medicine · Jiangxi Provincial People's Hopital · The Lichuan ethnic Hospital of Traditional Chinese Medicine · Xiangyang Central Hospital People's Hospital of Huangpi District · Quanzhou First Hospital · Minda Hospital of Hubei Minzu University · The Cerebrovascular Hospital of Hubei Province · The First People's Hospital of Changde City · Longyan First Affiliated Hospital of Fujian Medical University · Xiangzhou People's Hospital · Jingmen People's Hospital · The First People's Hospital of TianMen in Hubei Province · Hanyang Hospital, Wuhan University of Science & Technology · Tongcheng People's Hospital · Gaoyou People's Hospital · Zaoyang First People's Hospital · CR & WISCO General Hospital · Wuhan Hankou Hospital · Lu'an People's Hospital of Anhui Hospital · Yingtan People's Hospital · Shiyan Renmin Hospital · Dali Bai Autonomous Prefecture People's Hospital · Three Gorges Hospital of Chongqing University · The Second People's Hospital of Jingzhou City · General Hospital of the Yangtze River Shipping · The Affiliated Hospital Of Southwest Medical University · Fujian Provincial Hospital · Zhongxiang People's Hospital · LiuZhou People's Hospital · The Fifth Hospital of Wuhan · Xiaogan First People's Hospital · Loudi Central Hospital · Ezhou Central Hospital · Second Xiangya Hospital of Central South University · Qingdao Central Hospital · Taizhou First People's Hospital · Renmin Hospital of Wuhan University · Hubei Provincial Hospital of Integrated Chinese & Western Medicine · The First Affiliated Hospital of Botou Medical College · Xianfeng People's Hospital · Wuhan Third Hospital · The Fourth Hospital of Wuhan · Chengdu Fifth People's Hospital · Xingyi People's Hospital · Affiliated Hospital of Shandong University of Traditional Chinese Medicine · Shenzhen Hospital of Southern Medical University · The Third People's Hospital of Jingzhou City · The First People's Hospital of Jiangxia District · Xihua People's Hospital · Shanghai East Hospital
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06265051 on ClinicalTrials.govOther trials for Androgen insensitivity syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07556042Machine Learning Prediction of Disease Progression in Adolescent Idiopathic ScoliosisIstanbul University
- RECRUITINGPHASE3NCT07520565A Multicentre, Randomised, Double-blind, Placebo-parallel Controlled Phase Ⅲ Clinical Trial Evaluating the Efficacy and Safety of BXOS110 Injection in the Treatment of Acute Ischaemic Stroke Within 3 Hours of Onset.Biocells (Beijing) Biotech Co.,Ltd
- RECRUITINGNANCT07321600Resisted Inspiratory Muscle Training Applied in Addition to PSSE-Schroth ExercisesHacettepe University
- RECRUITINGPHASE2, PHASE3NCT07003386Exploration of the Efficacy and Mechanism of Galantamine (an Extract From Lycoris Aurea) in Treating Ischemic StrokeShanghai Yueyang Integrated Medicine Hospital
- RECRUITINGPHASE2NCT07084012A Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of Intravenous Infusion of hUC-MSCs in Patients With AISShenzhen Wingor Biotechnology Co., Ltd.
- RECRUITINGPHASE3NCT07561827The Effect of Erector Spinae Plane Block (ESPB) on Pediatric Pain Management Following Posterior Spinal Fusion (PSF) SurgeryUniversity of California, San Francisco
- ACTIVE NOT RECRUITINGNANCT07194564Acute Training Effect Assessment in Adolescent Idiopathic ScoliosisThe University of Hong Kong
- RECRUITINGNANCT06242821Yoga for Back Pain in Adolescent ScoliosisJohns Hopkins University